Provision of the Australian Prescriber Online Journal

The Department requires that the service provider provides the Australian Prescriber journal so that it:

a) is a national, independent, and peer-reviewed journal providing critical commentary on drugs and therapeutics;

b) is a source of expert, balanced, impartial, reliable and up-to-date information for its readers by reviewing recent evidence where therapy is evolving and updating readers on therapeutics in their own and other fields;

c) provides publications that contain critical commentary on drugs and therapeutics for health professionals including post-market use;

d) is aimed at prescribing health professionals including specialists, general practitioners, pharmacists and nurse practitioners, as well as other interested individuals;

e) is published every two months online (six issues per calendar year), with a minimum of five articles per issue;

f) is available free-of-charge at all times;

g) is hosted on a dedicated and secure website also maintained/operated by the service provider;

h) is promoted to increase engagement and readership of the targeted audience; and

i) addresses Quality Use of Medicines (QUM) and diagnostic issues, and improves QUM outcomes.

Previously, the Department received these Services from an outgoing service provider which ceased operations on 31 December 2022. The successful Respondent will be required to assume responsibility for the Services during a transition-in phase before the commencement of the Services. For the current gap period between the cessation of delivery of the Services by the outgoing service provider and the commencement of the transition-in-phase, the Department will store essential Australian Prescriber information, data and resources in readiness for the commencement of the successful Respondent.